The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Formation of Amyloid Fibers Triggered by Phosphatidylserine-Containing Membranes
Abstract
Protein misfolding has been shown to be the direct cause of a number of highly devastating diseases such as Alzheimer's disease, Parkinson's disease, and Creutzfeldt-Jacob syndrome, affecting the aging population globally. The deposition in tissues of amyloid fibrils is a characteristic of all these diseases, and the mechanisms by which these protein aggregates form continue to be intensively investigated. In only a fraction of cases is an underlying mutation responsible, and accordingly, what initiates amyloid formation in vivo is the major question that is addressed. In this study, we show that membranes containing phosphatidylserine (PS), a negatively charged phospholipid, induce a rapid formation of fibers by a variety of proteins, viz., lysozyme, insulin, glyceraldehyde-3-phosphate dehydrogenase, myoglobin, transthyretin, cytochrome c, histone H1, and alpha-lactalbumin. Congo red staining of these fibers yields the characteristic light green birefringence of amyloid, and fluorescent lipid tracers further reveal them to include phospholipids. Our results suggest that PS as well as other acidic phospholipids could provide the physiological low-pH environment on cellular membranes, enhancing protein fibril formation in vivo. Interestingly, all the proteins mentioned above either are cytotoxic or induce apoptosis. PS-protein interaction could be involved in the mechanism of cytotoxicity of the aggregated protein fibrils, perturbing membrane functions. Importantly, our results suggest that this process induced by acidic phospholipids may provide an unprecedented and generic connection between three current major areas of research: (i) mechanism(s) triggering amyloid formation, (ii) cytotoxicity of amyloidal protein aggregates, and (iii) mechanism(s) of action of cytotoxic proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
Amyloid fibrillogenesis: themes and variations
Rochet, J.-C., & Lansbury, P. T. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00049-4 · Cited by 1,095
Utsugi, T., Schroit, A. J., Connor, J., Bucana, C. D., & Fidler, I. J. (1991) · PubMed · Cited by 594
A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties
Si, K., Lindquist, S., & Kandel, E. R. (2003) · Cell · doi:10.1016/s0092-8674(03)01020-1 · Cited by 563
Volles, M. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0121353 · Cited by 487
Structure of a Cholesterol-Binding, Thiol-Activated Cytolysin and a Model of Its Membrane Form
Rossjohn, J., Feil, S. C., McKinstry, W. J., Tweten, R. K., & Parker, M. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80251-2 · Cited by 461
Bokvist, M., Lindström, F., Watts, A., & Gröbner, G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.11.046 · Cited by 375
Research works printed but not linked: 39
- Aguzzi A., 2003, Science 302, 814−818.
- Kayed R., 2003, Science 300, 486−489.
- Bucciantini M., 2002, Nature 416, 507−511.
- Si K., 2003, Cell 115, 879−891.
- Kinnunen P. K. J., 1994, Chem. Phys. Lipids 73, 181−207.
- Cole R. D., 1989, Methods Enzymol. 170, 524−532.
- Kraayenhof R., 1993, Biochemistry 32, 10057−10066.
- Rytömaa M., 1996, Biochemistry 35, 4529−4539.
- Subramanian M., 1998, Biochemistry 37, 1394−1402.
- Koiv A., 1995, DNA, and liposomes, Biochemistry 34, 8018−8027.
- Terzi E., 1994, Biochemistry 33, 7434−7441.
- Kim I.-C., 1967, Am. J. Pathol., 50
- Volles M. J., 2001, Biochemistry 40, 7812−7819.
- Zhu M., 2002, J. Biol. Chem., 277
- Lehtonen J. Y. A., 1996, Biophys. J., 70
- Lee E.-N., 2003, J. Neurochem., 84
- Hammarström P., 2001, Biochemistry 40, 11453−11459.
- Sousa M. M., 2003, Prog. Neurobiol. 71, 385−400.
- Chakrabartty A., 2001, Proc. Natl. Acad. Sci. U.S.A. 98
- Wells K., 1995, Neurochem. Res. 20, 1329−1333.
- Ishitani R., 2003, Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27, 291−301.
- Rossjohn J., 1997, Cell 89, 685−692.
- Volles M. J., 2002, Biochemistry 41, 4595−4602.
- Utsugi T., 1991, Cancer Res. 51, 3062−3066.
- Ran S., 2002, Int. J. Radiat. Oncol. Biol. Phys., 54
- Cook A. M., 1972, Nature 239, 150−151.
- Bose S., 2004, Anal. Biochem. (in press).
- Konishi A., 2003, Cell 114, 673−688.
- Zhao H., 2004, Biochemistry (in press).
- Kuboi R., 2000, J. Biosci. Bioeng., 90, 19, 10.1016/S1389-1723(00)80027-4 · doi:10.1016/s1389-1723(00)80027-4
- Sava G., 1989, Anticancer Res. 9, 583−591.
- Farias R. N., 1986, J. Biol. Chem., 261, 10.1016/S0021-9258(18)66742-0 · doi:10.1016/s0021-9258(18)66742-0
- Porras A., 2003, Endocrinology 144, 5390−5401.
- Pitcher W. H., 2002, Biochim. Biophys. Acta, 1564
- Bergers J. J., 1995, J. Liposome Res., 5, 10.3109/08982109509018632 · doi:10.3109/08982109509018632
- D'Agnillo F., 2002, 33, 1153−1164.
- Yang J., 1997, Science 275, 1129−1132.
- Svanborg C., 2003, Adv. Cancer Res. 88, 1−29.
- Abbreviations, brainPS, brain phosphatidylserine
Cited by
Amyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies
Nasica-Labouze, J., Nguyen, P. H., Sterpone, F., Berthoumieu, O., Buchete, N.-V., Coté, S., De Simone, A., Doig, A. J., Faller, P., Garcia, A., et al. (2015) · Chemical Reviews · doi:10.1021/cr500638n · Cited by 584
Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane
Engel, M. F. M., Khemtémourian, L., Kleijer, C. C., Meeldijk, H. J. D., Jacobs, J., Verkleij, A. J., de Kruijff, B., Killian, J. A., & Höppener, J. W. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708354105 · Cited by 466
Membranes: A meeting point for lipids, proteins and therapies
Escribá, P. V., González‐Ros, J. M., Goñi, F. M., Kinnunen, P. K. J., Vigh, L., Sánchez‐Magraner, L., Fernández, A. M., Busquets, X., Horváth, I., & Barceló‐Coblijn, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00281.x · Cited by 454
Self-citationImmunogenicity of protein aggregates—Concerns and realities
Wang, W., Singh, S. K., Li, N., Toler, M. R., King, K. R., & Nema, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.040 · Cited by 266
Sparr, E., Engel, M. F. M., Sakharov, D. V., Sprong, M., Jacobs, J., de Kruijff, B., Höppener, J. W. M., & Antoinette Killian, J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.075 · Cited by 257
How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?
SHAW, B., & VALENTINE, J. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.12.005 · Cited by 254
Identification of an Aggregation-Prone Structure of Tau
Elbaum-Garfinkle, S., & Rhoades, E. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305206m · Cited by 149
Burke, K. A., Yates, E. A., & Legleiter, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00017 · Cited by 127
Metadata
- Authors
- Zhao, H., Tuominen, E. K. J., & Kinnunen, P. K. J.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-07-20
- Volume
- 43
- Issue
- 32
- Pages
- 10302-10307
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1997822065
- Cited by
- 273
- References
- 37
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.